Category: Antibacterial and Antiviral Polymers

Infectious disease has become a growing global concern. Annually, there are 12 million deaths attributable to infectious diseases on the world and million dollars of added healtcare costs. The appearance of new antibiotic resistant bacterial strains and the increasing occurrences of community-type outbreaks and clearly this is an important global problem. Therefore, synthesis new antibacterial agents and learning how to control bacterial infections are an important endeavor.


Recently, the ongoing SARS-CoV-2 pandemic (referred to as COVID-19, Coronavirus disease 2019) has caused over 2,000,000 infections and over 250,000 deaths in 199 countries. Hence, this spread of infection, in principle, could be prevented if new vaccine or drug that kills efficiently and surface coating of implant or medical compounds common things encountered by people that inactivate influenza virus or bacteria. Here, we are targeting to synthesize a polymer based new compounds that can inactivate the viruses and bacteria in solution and as well as solid surface.

Materials applications and the development of permanently antibacterial surfaces are important part of controlling the spread of infectious disease. Eren research group is intended to develop an understanding of the structure-activity relationship of antibacterial and antiviral agent, by investigating their antibacterial,  antiviral and hemolytic activities using biophysical techniques.